A model for harmonizing flow cytometry in clinical trials.
| dc.contributor.author | Maecker, Holden T | |
| dc.contributor.author | McCoy, J Philip | |
| dc.contributor.author | FOCIS Human Immunophenotyping Consortium | |
| dc.contributor.author | Amos, Michael | |
| dc.contributor.author | Elliott, John | |
| dc.contributor.author | Gaigalas, Adolfas | |
| dc.contributor.author | Wang, Lili | |
| dc.contributor.author | Aranda, Richard | |
| dc.contributor.author | Banchereau, Jacques | |
| dc.contributor.author | Boshoff, Chris | |
| dc.contributor.author | Braun, Jonathan | |
| dc.contributor.author | Korin, Yael | |
| dc.contributor.author | Reed, Elaine | |
| dc.contributor.author | Cho, Judy | |
| dc.contributor.author | Hafler, David | |
| dc.contributor.author | Davis, Mark | |
| dc.contributor.author | Fathman, C Garrison | |
| dc.contributor.author | Robinson, William | |
| dc.contributor.author | Denny, Thomas | |
| dc.contributor.author | Weinhold, Kent | |
| dc.contributor.author | Desai, Bela | |
| dc.contributor.author | Diamond, Betty | |
| dc.contributor.author | Gregersen, Peter | |
| dc.contributor.author | Di Meglio, Paola | |
| dc.contributor.author | Nestle, Frank O | |
| dc.contributor.author | Peakman, Mark | |
| dc.contributor.author | Villanova, Federica | |
| dc.contributor.author | Ferbas, John | |
| dc.contributor.author | Field, Elizabeth | |
| dc.contributor.author | Kantor, Aaron | |
| dc.contributor.author | Kawabata, Thomas | |
| dc.contributor.author | Komocsar, Wendy | |
| dc.contributor.author | Lotze, Michael | |
| dc.contributor.author | Nepom, Jerry | |
| dc.contributor.author | Ochs, Hans | |
| dc.contributor.author | O'Lone, Raegan | |
| dc.contributor.author | Phippard, Deborah | |
| dc.contributor.author | Plevy, Scott | |
| dc.contributor.author | Rich, Stephen | |
| dc.contributor.author | Roederer, Mario | |
| dc.contributor.author | Rotrosen, Dan | |
| dc.contributor.author | Yeh, Jung-Hua | |
| dc.coverage.spatial | United States | |
| dc.date.accessioned | 2017-06-02T12:56:12Z | |
| dc.date.available | 2017-06-02T12:56:12Z | |
| dc.date.issued | 2010-11 | |
| dc.description.abstract | Complexities in sample handling, instrument setup and data analysis are barriers to the effective use of flow cytometry to monitor immunological parameters in clinical trials. The novel use of a central laboratory may help mitigate these issues. | |
| dc.identifier | ||
| dc.identifier | ni1110-975 | |
| dc.identifier.eissn | 1529-2916 | |
| dc.identifier.uri | ||
| dc.language | eng | |
| dc.publisher | Springer Science and Business Media LLC | |
| dc.relation.ispartof | Nat Immunol | |
| dc.relation.isversionof | 10.1038/ni1110-975 | |
| dc.subject | Clinical Trials as Topic | |
| dc.subject | Flow Cytometry | |
| dc.subject | Humans | |
| dc.subject | Specimen Handling | |
| dc.title | A model for harmonizing flow cytometry in clinical trials. | |
| dc.type | Journal article | |
| pubs.author-url | ||
| pubs.begin-page | 975 | |
| pubs.end-page | 978 | |
| pubs.issue | 11 | |
| pubs.organisational-group | Basic Science Departments | |
| pubs.organisational-group | Clinical Science Departments | |
| pubs.organisational-group | Duke | |
| pubs.organisational-group | Duke Cancer Institute | |
| pubs.organisational-group | Duke Human Vaccine Institute | |
| pubs.organisational-group | Immunology | |
| pubs.organisational-group | Institutes and Centers | |
| pubs.organisational-group | Medicine | |
| pubs.organisational-group | Medicine, Duke Human Vaccine Institute | |
| pubs.organisational-group | Pathology | |
| pubs.organisational-group | School of Medicine | |
| pubs.organisational-group | Surgery | |
| pubs.organisational-group | Surgery, Surgical Sciences | |
| pubs.publication-status | Published | |
| pubs.volume | 11 |